Company History

Biocare Medical was founded in the summer of 1997 by the present owners of the company Roy Paxton Yih-CEO, Gene Castagnini-CFO, and Dr. David Tacha – Chief Scientific Officer.


Patented Antigen Retrieval (Decloaking) Chamber launched

Mach Series Polymer Detection & Multiplex IHC Antibody line launched

Simultaneous Multiplex IHC technology –patent pending- PIN-4

3000 Decloaking Chambers sold
Rabbit Monoclonal capability
Fluorescent signal amplification with Mach Series Detection launched

intelliPATH FLX™ and SPOT-Light® HER2 CISH launched

19 New Antibodies with 2 New Multiplex IHC products – URO-3 (Bladder) and ADH-5 (Breast)

15 New Antibodies with 4 New Multiplex IHC products: CD4/CD8, GPC3/CK19, TTF1/Napsin A, P63/CK5
RISH – in situ hybridization simplified (MRNA) Launched